Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$62M |
 |
Mind Medicine (MindMed)MNMD |
-$44M |
 |
ModernaMRNA |
-$256B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Fox Christine | Nov 20, 2024 | Sell | 19,388 | $16.8705 | $330,000 |
| Daniell Richard | Aug 12, 2024 | Sell | 98,943 | $17.2973 | $1.7M |
| Hughes Eric A | Aug 9, 2024 | Sell | 45,060 | $17.3762 | $780,000 |
| Grant Angus | Aug 9, 2024 | Sell | 4,065 | $17.28 | $70,000 |
| Hughes Eric A | Aug 1, 2024 | Sell | 24,537 | $17.2507 | $420,000 |
| MIGNONE ROBERTO | Jun 18, 2024 | Sell | 519,000 | $17.03 | $8.8M |
| Weiss Amir | May 16, 2024 | Sell | 12,635 | $16.6503 | $210,000 |
| Weiss Amir | May 15, 2024 | Sell | 15,500 | $16.8011 | $260,000 |
| Conway Vikki L | May 13, 2024 | Sell | 15,219 | $16.7427 | $250,000 |
| Kalif Eliyahu Sharon | Mar 6, 2024 | Sell | 77,550 | $13.5154 | $1M |
| Sabag Mark | Mar 5, 2024 | Sell | 100,000 | $13.5209 | $1.4M |
| Daniell Richard | Mar 5, 2024 | Sell | 26,053 | $13.5154 | $350,000 |
| Daniell Richard | Mar 5, 2024 | Sell | 22,576 | $13.5154 | $310,000 |
| Conway Vikki L | Mar 5, 2024 | Sell | 1,427 | $13.5154 | $19,000 |
| Francis Richard D | Mar 4, 2024 | Sell | 31,061 | $13.3373 | $410,000 |
| Daniell Richard | Mar 4, 2024 | Sell | 62,250 | $13.3373 | $830,000 |
| Daniell Richard | Mar 4, 2024 | Sell | 33,512 | $13.3373 | $450,000 |
| Conway Vikki L | Mar 4, 2024 | Sell | 2,042 | $13.3733 | $27,000 |
| Conway Vikki L | Mar 4, 2024 | Sell | 1,490 | $13.3733 | $20,000 |
| Hughes Eric A | Mar 4, 2024 | Sell | 8,045 | $13.3373 | $110,000 |
| Daniell Richard | Feb 28, 2024 | Sell | 20,599 | $13.116 | $270,000 |
| Drape Eric | Feb 28, 2024 | Sell | 9,815 | $13.116 | $130,000 |
| Conway Vikki L | Feb 28, 2024 | Sell | 1,366 | $13.116 | $18,000 |
| Drape Eric | Feb 16, 2024 | Sell | 173,261 | $13.0549 | $2.3M |
| Francis Richard D | Feb 15, 2024 | Sell | 74,530 | $13.1514 | $980,000 |
| Weiss Amir | Feb 1, 2024 | Sell | 31,766 | $12.3703 | $390,000 |
| Kalif Eliyahu Sharon | Aug 7, 2023 | Sell | 35,125 | $9.7335 | $340,000 |
| Weiss Amir | Aug 4, 2023 | Sell | 1,981 | $9.921 | $20,000 |
| Hughes Eric A | Aug 1, 2023 | Sell | 52,742 | $8.2987 | $440,000 |
| Stark David Matthew | Mar 7, 2023 | Sell | 49,475 | $9.4279 | $470,000 |
| Dethlefs Sven | Mar 7, 2023 | Sell | 58,066 | $9.4279 | $550,000 |
| Daniell Richard | Mar 7, 2023 | Sell | 54,007 | $9.4279 | $510,000 |
| Drape Eric | Mar 7, 2023 | Sell | 4,699 | $9.4279 | $44,000 |
| Stark David Matthew | Mar 6, 2023 | Sell | 16,491 | $9.9309 | $160,000 |
| Dethlefs Sven | Mar 6, 2023 | Sell | 19,355 | $9.9309 | $190,000 |
| Daniell Richard | Mar 6, 2023 | Sell | 18,002 | $9.9309 | $180,000 |
| Drape Eric | Mar 6, 2023 | Sell | 1,566 | $9.9309 | $16,000 |
| Stark David Matthew | Feb 28, 2023 | Sell | 44,953 | $9.8866 | $440,000 |
| Stark David Matthew | Feb 28, 2023 | Sell | 18,430 | $9.8866 | $180,000 |
| Drape Eric | Feb 28, 2023 | Sell | 23,888 | $9.8866 | $240,000 |
| Dethlefs Sven | Feb 28, 2023 | Sell | 42,309 | $9.8866 | $420,000 |
| Dethlefs Sven | Feb 28, 2023 | Sell | 17,346 | $9.8866 | $170,000 |
| Daniell Richard | Feb 28, 2023 | Sell | 23,654 | $9.8866 | $230,000 |
| Daniell Richard | Feb 28, 2023 | Sell | 20,598 | $9.8866 | $200,000 |
| Drape Eric | Feb 28, 2023 | Sell | 9,797 | $9.8866 | $97,000 |
What's the latest insider transaction for Teva Pharmaceutical?
The most recent insider transaction for Teva Pharmaceutical was conducted by Fox Christine, who sold 19,388 shares on November 20, 2024 at a price of $16.87 per share.
Which insider has sold the most TEVA stock over the last two years?
MIGNONE ROBERTO has sold the most TEVA stock in the last 2 years, with a total value of $8.8M.
What is the total value of insider transactions for Teva Pharmaceutical (TEVA) in the last 2 years?
The total value of insider transactions for Teva Pharmaceutical in the last 2 years is negative, amounting to -$27M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Teva Pharmaceutical's market confidence?
Over the last 2 years, insider transactions for Teva Pharmaceutical have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
